← Evidence map

ArticleAnnals of hematology2025

Tafasitamab in refractory diffuse large B-cell lymphoma with neurolymphomatosis.

João Ricardo Belo Freitas Mendes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39934427